An increase in Orai1, but not Stim1, levels has also been reported in several breast cancer cell (BCC) lines [11], while the loss of Stim1 protein prevents SOCE activation in Wilms tumor cells [69]. Here, STIM1 is linked to skin basal cell carcinoma.